Related Experiment Video
Updated: Apr 4, 2026

Modeling Hypoxia/Reoxygenation Injury in Proximal Tubular Epithelial Cells
Published on: November 21, 2025
Mitochondria: a therapeutic target in acute kidney injury
1Division of Nephrology and Endocrinology, The University of Tokyo Graduate School of Medicine, Tokyo, Japan.
Abstract:
Acute kidney injury (AKI) is a common clinical entity that is associated with high mortality and morbidity. It is a risk factor for the development and progression of chronic kidney disease. Presently, no effective treatment for AKI is available, and novel therapeutic approaches are desperately needed. Accumulating evidence highlights mitochondrial dysfunction as an important factor in the pathogenesis of AKI. Recent advances in our understanding of the molecules involved in mitochondrial biogenesis, fusion/fission, mitophagy and their pathophysiological roles will lead to the development of drugs that target mitochondria for the treatment of various diseases, including AKI. In this review, we summarize current knowledge of the contribution of mitochondria-related pathophysiology in AKI and the prospective benefits of mitochondria-targeting therapeutic approaches against AKI.
Insights
Mitochondrial dysfunction contributes to acute kidney injury (AKI), a condition lacking effective treatments. Targeting mitochondria offers a promising therapeutic strategy for AKI.
Area of Science:
- Nephrology
- Mitochondrial Biology
- Pathophysiology
Background:
- Acute kidney injury (AKI) presents significant mortality and morbidity risks.
- AKI is a precursor to chronic kidney disease.
- Current treatments for AKI are limited, necessitating novel therapeutic strategies.
Purpose of the Study:
- To review the role of mitochondrial dysfunction in AKI pathogenesis.
- To explore the potential of mitochondria-targeting therapies for AKI treatment.
Main Methods:
- Literature review of recent advances in mitochondrial biology.
- Analysis of pathophysiological roles of mitochondrial biogenesis, fusion, fission, and mitophagy.
Main Results:
- Mitochondrial dysfunction is a key factor in AKI development.
- Understanding mitochondrial dynamics provides insights into AKI pathology.
Conclusions:
- Mitochondria-centric pathophysiology is crucial in AKI.
- Mitochondria-targeting therapeutics hold promise for treating AKI.
Related Concept Videos
Acute Kidney Injury II: Pathophysiology
Acute Kidney Injury I: Introduction
Acute Kidney Injury V: Interprofessional Care
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Acute Kidney Injury III: Clinical Manifestations
Acute Kidney Injury VI: Nursing Management

